iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.7550
+0.0450 (6.34%)
At close: Jun 27, 2025, 4:00 PM
0.7298
-0.0252 (-3.34%)
After-hours: Jun 27, 2025, 7:56 PM EDT

iBio, Inc. Market Cap

iBio, Inc. has a market cap or net worth of $12.47 million as of June 27, 2025. Its market cap has decreased by -39.75% in one year.

Market Cap
12.47M
Enterprise Value
11.83M
1-Year Change
-39.75%
Ranking
Category
Stock Price
$0.76

Market Cap Chart

Since November 16, 2009, iBio, Inc.'s market cap has decreased from $27.70M to $12.47M, a decrease of -54.97%. That is a compound annual growth rate of -4.98%.

History

DateMarket Cap% Change
Jun 26, 202511.60M-48.21%
Dec 31, 202422.40M1,078.95%
Dec 29, 20231.90M-52.50%
Dec 30, 20224.00M-96.66%
Dec 31, 2021119.70M-37.40%
Dec 31, 2020191.20M2,320.25%
Dec 31, 20197.90M-43.57%
Dec 31, 201814.00M-14.63%
Dec 29, 201716.40M-53.41%
Dec 30, 201635.20M-18.71%
Dec 31, 201543.30M-12.17%
Dec 31, 201449.30M128.24%
Dec 31, 201321.60M-27.03%
Dec 31, 201229.60M10.04%
Dec 30, 201126.90M-73.23%
Dec 31, 2010100.50M298.81%
Dec 31, 200925.20M-9.03%
View and export this data all the way back to 2009. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 698.51B
Johnson & Johnson 366.18B
AbbVie 327.76B
Novo Nordisk 313.40B
UnitedHealth Group 277.24B
Abbott Laboratories 240.24B
Novartis AG 232.39B
AstraZeneca 218.32B
Market Cap Rankings